Drug Company Reaches $13M Settlement With SEC Over Accounting Fraud Claims

(September 29, 2017, 5:24 PM EDT) -- WASHINGTON, D.C. — Medical manufacturer Alere Inc. will pay more than $13 million to settle claims with the Securities and Exchange Commission that it engaged in accounting fraud and made improper payments for foreign officials through its foreign subsidiaries in violation of federal securities laws, according to an SEC cease-and-desist order filed Sept. 28 (In the Matter of Alere Inc., No. 3-18228, SEC)....

Attached Documents

Related Sections